BRBR: What Is the Market Really Pricing After the Selloff?
BellRing, Premier Protein, Kirkland, and the GLP-1 protein trade
BellRing Brands (BRBR) looks like a very straightforward company on the surface. It sells protein shakes.
More specifically, BellRing Brands is incredibly dependent on Premier Protein ready-to-drink shakes. Think of the product most people know: Costco’s 11oz bottled shake sold by the case at Costco, Sam’s Club, Walmart, and Amazon. 30g of protein, low sugar, low calories, ready to drink.
This isn’t hardcore gym powder. It is positioned much closer to a daily nutrition tool. Think of it as a breakfast replacement, weight loss protein supplement, muscle-loss hedge for GLP-1 users, or quick meal alternative at the office.
That convenient positioning is also why BRBR is compelling. It trades directly on top of a genuine consumer trend. US consumers are increasingly focusing on their protein intake. GLP-1 drugs have amplified the trend telling them they may be eating less food, but they still need sufficient protein. Premier Protein has clear positioning, broad shelf penetration, strong repeat purchase behavior, and a history of high growth.
The market isn’t just asking if that protein trend can continue growing from here. The market is asking a much meaner question:
Can Premier Protein protect any semblance of its historical margin structure?
It’s Not Coca-Cola. It’s a Nutrition Spec Sheet.
Premier Protein’s core value prop is quite simple: 30 grams of protein, low sugar, low calories, at a relatively cheap price.
That is both its advantage and its vulnerability.
Coca-Cola doesn’t just sell soda. It also sells taste memory, identity, ritual, and supply/distribution network control. If Coke were $0.10 more expensive than private label at the supermarket, most consumers still would not switch. Premier Protein is not Coke.
Premier Protein’s value prop is simple “how much protein, how many calories, how much sugar, and how much does it cost?” The purchase decision is very functional.
When your go-to-buy specs become a spec sheet, private label loves what they see.
Costco’s Kirkland brand, Sam’s Club’s Member’s Mark, BJ’s Wellsley Farms, and other retailer owned brands are attacking directly on price by taking a similar protein count, calorie count, sugar count, and similar packaging/form-factor, then cutting prices on their store brands.
Premier does not need to be wiped out by private label for the shareholders to lose money. It just needs to be marginally taxed by private label.
That margin tax does not need to come from one dramatic private label shelf event. It happens slowly through deeper promotions, worse price/mix, higher shelf costs, and ultimately, a lower and weaker steady-state margin.
Asset-Light Is the Other Side of the Coin
BRBR is an asset-light company. It does not own much manufacturing capacity. Outsourced production through third party co-packers fuel most of its growth. BellRing owns the brand, owns the formulation, has relationships in the channels, spends on advertising, and determines promotion strategy. Production is contracted to third parties.
When times are good, this looks like a phenomenal business. Little capital intensity, high cash returns, and growth accelerates through the funnel quite well.
When times are bad, however, you see the other side of asset-light.
BRBR does not have its own direct-store-delivery trucks and drivers like Coca-Cola, Pepsi, or Monster. BRBR ships product into retailer distribution centers. After that, shelf placement, replenishment cycles, promotional timing, and even consumer level sales data lives predominantly in the retailer’s hands.
BRBR simply does not have eyes and hands on the shelf.
This wouldn’t be so bad if BRBR’s customer base was hyper diversified. However, Walmart/Sam’s Club, Costco, and Amazon are massive revenue drivers. While these are customers just like any other, they are also capable of becoming competitors.
Once Costco stocks a Kirkland branded protein shake next to Premier Protein, BRBR is no longer competing against a normal competitor. BRBR is going head-to-head with the landlord.
The Title Says It All: Demand Didn’t Die. Unit Economics Got Worse.
BRBR was a high-velocity consumer stock. Revenue grew in FY2025 and Premier Protein is still near the top of the category in terms of units. But coming into FY2026, the growth story has become muddied in investors’ minds. They’re beginning to see a margin-collapse story instead.
Volume has not died. However, the quality of revenue is getting washed out.
Premier ready-to-drink shakes are volume growing. More of that volume is sold on promotion versus clean price. Volume is being offset by negative price/ mix. This implies consumers are training themselves to wait on promotions, and retailers are extracting more promotion from the brand.
Costs are also becoming more aggressive. Dairy protein, whey, freight, tariffs, and inventory write-downs have all pressured gross margin.
The old BRBR was rewarded by the market because it believed in the story of a high-quality asset light growth curve with EBITDA margins near 20%.
The question now is whether FY2026 is a temporary trough or a new normal.
That is the valuation question.
Fairlife, Kirkland, and Nurri Loading Pressure From Three Sides
This pressure is especially impactful from a consumer perspective.
Occupying the premium spot on shelves is Fairlife. Owned by Coca-Cola, its milk base is ultra-filtered. The product actually tastes more like chocolate milk. In casual consumer conversations and online reviews, Fairlife has better taste equity. Users are consistently willing to pay up for the premium.
Occupying the value spot on shelves are Kirkland and the myriad of other private-label options. They do not need to win a taste test with Fairlife. They just need to be “good enough” and priced far cheaper. Given that it is a functional consumer product, that may be enough for retailers and consumers.
To the side are Nurri, Oikos, Muscle Milk, Quest, Atkins, Ensure, Boost, and dozens of other occasion-based competitors. The protein beverage category will continue to grow, but category growth does not inherently lead to monopoly economics. More growth just means more entrants, more shelf negotiations, and more promotions.
So investors should not worry about whether demand is dying for BRBR. I do not think demand is going away.
The issue is where the value goes as the category continues to grow. Does the brand owner capture it? Do retailers? The co-packer? The dairy protein supplier upstream?
Equity Looks Like a Call Option Behind Debt
Risk is further compounded by BRBR’s capital structure.
BRBR is not a net cash consumer staples company. It has $1.2 billion of debt plus legal reserves that sit above common equity. Common shareholders are behind those creditors and claims on the company. EV needs to first pay off creditors and other liabilities before equity holders see a dollar.
If Premier Protein’s margins recover, there is tremendous upside to equity. However, if margins are reset lower on a permanent basis, equity can decline very quickly.
The business could go from “great” to “good.” But with financial leverage in the capital structure, shareholders can experience outcomes that go from “multi-bagger” to “total loss.”
That is why I do not think investors should look at BRBR through a single-point DCF. The valuation is not linear. It is about probability and payoff.
How I Would Frame the Scenarios
I don’t believe BRBR should be viewed through the lens of one precise target price. I prefer to break it out into discrete scenarios.
Scenario 1: Near-Zero
The probability isn’t necessarily high, but we have to start with how a collapse could play out. If promotions are ever made permanent, margins keep compressing, cash flow continues to deteriorate, refinancing pressures mount, and litigation creates additional headwinds, there is a scenario where common equity could be wiped out and replaced with option value. In this extreme outcome, BRBR might trade at around $0–2, with an estimated median of $1.
Scenario 2: Structural Bear
The company limps along, Premier still sells product, but the Kirkland tax remains, and input costs stay elevated. In this world, EBITDA remains depressed and cash conversion is permanently weakened. If that happens, the stock may be worth around $4–6, with a center somewhere around $5.
Scenario 3: Partial Reset
While still severe, Premier’s problems don’t fully become permanent, but neither do past margins fully return. Advertising dollars, promotion expenses, and pressure from private label permanently take a few points off steady-state profitability. Margin expansion still occurs, but from a lower base than in the past. I view this as my most likely outcome. In this scenario the stock may be worth around $15–19, with a center somewhere around $17.
Scenario 4: Full Recovery
FY2026 suffers as an anomaly caused by temporary factors that converge at once: cost pressures, inventory issues, heavy promotion spending, distribution channel transition, etc. Dairy protein costs come down, Kirkland doesn’t gain brand equity and manage to replace Premier as a habitual purchase, and Fairlife’s higher price points give Premier room to rebound. Business returns to historical mid-cycle profitability. Shares may be worth $22–24 in this scenario, with a center somewhere around $23.
Scenario 5: Bull Case / Strategic Transaction
Premier not only recovers. It gets re-rated by a strategic purchaser with better direct-store-delivery muscle and relationships, or management successfully unlocks new channels like convenience, single-serve, chilled immediate consumption, or broader beverage distribution. Shares could trade $28–45 in this scenario, with a center around $34.
I’m willing to give these scenarios the following rough probability framework: 7% chance near-zero; 23% chance of structural bear; 40% chance partial reset; 20% chance full recovery; and 10% chance bull case/acquisition. Expected value under that framework comes out to roughly $16 per share. Against a reference price in the $13.44 neighborhood from the other piece of material, the odds look favorable to me, but not by a huge margin of safety.
Why I Would Not Assign a High Takeout Probability
BRBR does have M&A optionality. Protein ready-to-drink is a big category and Premier has real equity built up over the years in terms of brand, actual share, and shelf-space stake. For a buyer like KDP or Pepsi that already has direct-store-delivery relationships with key grocery retailers, Premier’s inability to control inventory effectively is actually one of their strengths.
The catch with takeouts though is that they aren’t quite as simple as “great asset, must have buyer.”
The buyer typically wants to see evidence that the business has stabilized before they are willing to pay an acquisition premium on top of a normal multiple. The seller typically doesn’t want to sell the business at the bottom of a major guidance collapse. Today we find ourselves in the awkward position where management wants valuation discussions to begin with mid-cycle profit levels while the buyer refuses to look past trough profits. When two sides can’t agree where to begin valuation discussions based on divergent price anchors, M&A deals don’t happen.
The buyer universe isn’t perfect either. Coca-Cola already owns Fairlife. PepsiCo has its own issues stabilizing margins in its sports nutrition business and has broader portfolio priorities to consider. KDP is working through a major coffee transaction and corporate separation at the same time. Private equity would need to underwrite the existing debt burden atop uncertain steady-state margins.
I view M&A as real upside optionality for BRBR, but should be treated as more of a low-frequency high-impact event than part of the base case.
Final Conclusion
BRBR is not a boring “cheap consumer leader” story. The fundamental payoff is going to be more structurally complex than that.
The core category is still attractive. But control over the supply/demand curve is being taken away from Premier and given to retailers, private label, co-packers, and dairy protein producers upstream.
The long case is not simply “protein shakes will grow.” Instead it’s a more narrow bet that FY2026 profit margins do not become the permanent new normal, and that Premier can continue to maintain acceptable unit economics despite pressure from Fairlife and private label.
The short case is not “consumers will stop drinking Premier”. Rather, it’s that consumers increasingly make their purchase decision like they would a spec sheet, retailers treat Premier like any other replaceable shelf item, and permanent margin compression ensues on the brand rent that used to be taken for granted.
BRBR strikes me as having positive expected value today, but not nearly high enough certainty as a compounder. The risk/reward feels better suited for a small position bet in your portfolio that you explicitly recognize has left-tail risk. It’s better viewed as an odds-based investment than a core consumer staples holding. The real margin of safety comes from being humble enough to recognize that even if the brand survives and thrives with consumers, shareholders might not see all the profit they once did.
Disclaimer: This article is being written for my own personal research and investment-framework purposes only. It is not intended to be investment advice, securities recommendation, or an offer to buy or sell any security. All valuation ranges, probabilities, and scenarios discussed represent my own subjective judgments and may have errors or omissions. Investing always involves risks. Readers should verify company filings, financial data, and market prices for themselves, and make their own investment decisions based on their own risk tolerances and objectives.